Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Nina Orfali"'
Publikováno v:
Clinical Case Reports, Vol 12, Iss 7, Pp n/a-n/a (2024)
Key Clinical Message VEXAS syndrome (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic) is a novel autoinflammatory syndrome. We describe a case of VEXAS syndrome with upper airway and oral cavity involvement which are not well described in
Externí odkaz:
https://doaj.org/article/dd91d21fe9be447096c185398dfc33dc
Autor:
Nina Orfali, Deborah Shan‐Krauer, Tracey R. O’Donovan, Nigel P. Mongan, Lorraine J. Gudas, Mary R. Cahill, Mario P. Tschan, Sharon L. McKenna
Publikováno v:
Molecular Oncology, Vol 14, Iss 6, Pp 1297-1309 (2020)
Ubiquitin/ISG15‐conjugating enzyme E2L6 (UBE2L6) is a critical enzyme in ISGylation, a post‐translational protein modification that conjugates the ubiquitin‐like modifier, interferon‐stimulated gene 15 (ISG15), to target substrates. Previous
Externí odkaz:
https://doaj.org/article/d6f2dd270c9a47d8aa678254a9db298c
Autor:
Dalyia N. Benjamin, Tracey R. O’Donovan, Kristian B. Laursen, Nina Orfali, Mary R. Cahill, Nigel P. Mongan, Lorraine J. Gudas, Sharon L. McKenna
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Acute myeloid leukemia (AML) is an aggressive blood cancer with an overall survival of 30%. One form of AML, acute promyelocytic leukemia (APL) has become more than 90% curable with differentiation therapy, consisting of all-trans-retinoic acid (ATRA
Externí odkaz:
https://doaj.org/article/ae6989dc6889441b8fad712bc28c5e5e
Publikováno v:
Annals of Hematology. 102:1271-1274
Autor:
Alexandra Gomez-Arteaga, Nina Orfali, Michelle Pasciolla, Ayanna Baptiste, Inna Guindine, Jingmei Hsu, Jonathan Lin, Sebastian A. Mayer, Adrienne A. Phillips, Tsiporah B. Shore, Paul D. Simonson, Edward DiCarlo, Sung Yoon, Thangamani Muthukumar, Koen van Besien
Publikováno v:
Bone Marrow Transplantation.
Autor:
Markus Plate, Thomas J. Walsh, Koen van Besien, Sebastian Mayer, Alexandra Gomez-Arteaga, Alex Drelick, Hanna Rennert, Michael J. Satlin, Tsiporah B. Shore, Ok-Kyong Chaekal, Catherine B. Small, Rosemary Soave, Zhengming Chen, Rosy Priya L. Kodiyanplakkal, Jingmei Hsu, Nina Orfali, Adrienne A. Phillips
Publikováno v:
Leukemia & Lymphoma. 63:435-442
The incidence of adenovirus viremia and the role of screening in preventing adenovirus disease in adult transplant recipients are not well defined. Between January 2017 and May 2020, 262 allogeneic transplants were performed using in vivo T-cell depl
Publikováno v:
Transplantation and Cellular Therapy. 29:S421-S422
Autor:
James Dillon, Vitaliy Mykytiv, Catriona Keenan, Brendan Mullaney, Nina Orfali, Kevin Ryan, Cleona Duggan, Maeve P. Crowley
Publikováno v:
British journal of haematologyREFERENCES. 199(2)
Autor:
Chandni Patel, Michelle Pasciolla, Rachel Abramova, David Salerno, Alexandra Gomez-Arteaga, Tsiporah B. Shore, Nina Orfali, Sebastian Mayer, Jingmei Hsu, Adrienne A. Phillips, Ok-Kyong Chaekal, Michael J. Satlin, Rosemary Soave, Rosy Priya L. Kodiyanplakkal, Alexander Drelick, Markus Plate, Koen Van Besien
Publikováno v:
Transplantation and cellular therapy.
Epstein-Barr virus (EBV) reactivation and EBV-related post-transplantation lymphoproliferative disorder (PTLD) are often fatal complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The risk of EBV reactivation may be mit
Autor:
Adomah Opong, June Greenberg, Richard R. Furman, Adriana C Rossi, Michelle Pasciolla, Koen van Besien, Adrienne A. Phillips, Yuliya S. Jhanwar, Usama Gergis, Tsiporah B. Shore, Peter Martin, Tomer M Mark, John P. Leonard, Grace Suhu, Sarah C. Rutherford, Kathleen Maignan, Sebastian Mayer, Jessy Ryan, Danielle Guarneri, Roger N. Pearse, Calvin Koo, Jia Ruan, Maria Baldo, Jingmei Hsu, Edwidge Cuvilly, Nina Orfali
Publikováno v:
Leukemia & Lymphoma. 62:1629-1638
We evaluate the safety of bendamustine as a bridge to stem cell transplantation (SCT) in patients with relapsed/refractory lymphoma and residual disease after salvage therapy. Thirty-four subjects without complete responses (CR) received bendamustine